Coronavirus vaccines were just rolling out in December when more than 1,000 staffers at Cedars-Sinai Medical Center in Los Angeles volunteered for a sweeping study.

The story so far: Reports of rare blood clots occurring after COVID-19 vaccination have led some countries to limit the usage of AstraZeneca’s vaccine for certain categories of people, while other countries have paused the administration.